Identifying prothrombin and bone sialoprotein as potential drug targets for idiopathic pulmonary fibrosis
The integrative analysis suggests that Prothrombin and IBSP are promising candidates as potential drug targets for IPF. Additional clinical investigations are warranted to substantiate these findings.
Authors
- Siyu Cao (ORCID: https://orcid.org/0000-0002-4886-7071)
- Zhaohui Tong
- Yusha Chen (ORCID: https://orcid.org/0000-0002-2662-743X)
- Shuai Shao (ORCID: https://orcid.org/0000-0003-0699-1864)
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s12890-024-03289-y
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Ministry of Science and Technology of the People's Republic of China